Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-03

Clinical Trial Update: The Effect of Escitalopram in PCOS [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating escitalopram in polycystic ovary syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

Sponsor: Odense University Hospital | Conditions: Polycystic Ovary Syndrome | Phase 4 | Status: COMPLETED